Chemoinformaics analysis of N-VALEROPHENONE-O-CARBOXYLIC-ACID
| Molecular Weight | 206.241 | nRot | 5 |
| Heavy Atom Molecular Weight | 192.129 | nRig | 8 |
| Exact Molecular Weight | 206.094 | nRing | 1 |
| Solubility: LogS | -2.994 | nHRing | 0 |
| Solubility: LogP | 2.816 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 29 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 1 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 12 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 6 |
| nHA | 2 | APOL | 31.7811 |
| nHD | 1 | BPOL | 15.7809 |
| QED | 0.753 |
| Synth | 1.679 |
| Natural Product Likeliness | 0.011 |
| NR-PPAR-gamma | 0.682 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.009 |
| Pgp-sub | 0.001 |
| HIA | 0.007 |
| CACO-2 | -4.716 |
| MDCK | 0.0000225 |
| BBB | 0.496 |
| PPB | 0.84865 |
| VDSS | 0.218 |
| FU | 0.134517 |
| CYP1A2-inh | 0.266 |
| CYP1A2-sub | 0.166 |
| CYP2c19-inh | 0.078 |
| CYP2c19-sub | 0.058 |
| CYP2c9-inh | 0.283 |
| CYP2c9-sub | 0.192 |
| CYP2d6-inh | 0.021 |
| CYP2d6-sub | 0.105 |
| CYP3a4-inh | 0.021 |
| CYP3a4-sub | 0.085 |
| CL | 2.037 |
| T12 | 0.774 |
| hERG | 0.122 |
| Ames | 0.016 |
| ROA | 0.306 |
| SkinSen | 0.155 |
| Carcinogencity | 0.053 |
| EI | 0.973 |
| Respiratory | 0.547 |
| NR-Aromatase | 0.008 |
| Antiviral | No |
| Prediction | 0.649965 |